NCT04474717View on ClinicalTrials.gov

Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study)

NACompletedINTERVENTIONAL
Enrollment

476

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

July 19, 2023

Study Completion Date

July 19, 2023

Conditions
Chronic Obstructive Pulmonary DiseasePeripheral Artery Disease
Interventions
DIAGNOSTIC_TEST

Breath Condensate Collection

Breath Condensate Collection

DIAGNOSTIC_TEST

clinical examination, spirometry

spirometry

DIAGNOSTIC_TEST

blood monocyte assay

study of blood monocytes in the laboratory of cell technology

Trial Locations (1)

390005

Ryazan State Medical University, Ryazan

All Listed Sponsors
lead

Ryazan State Medical University

OTHER

NCT04474717 - Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis (Clinical and Biochemical Study) | Biotech Hunter | Biotech Hunter